Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma----[2] 96, 97 💬
2Also referred to as 'MEDI2070'Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 240-Product Name: BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----[1] 97 💬
3Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain)----[1] 271 💬
4Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human----[2] 96, 97 💬
5Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----[2] 96, 97 💬
6BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusion in pre-filled syringeINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----[1] 97 💬
7Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274 💬
8Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274 💬
9Diagnostic Test: 4 ml. of fresh venous blood will be collected from each patient on EDTA tube and will be used for detection of the following : T cell immunoglobulin G ( TIgG) and T cell immunoglobulin M (TIgM) by----[1] 49 💬
10HUMAN IMMUNOGLOBULIN G[1] Human immunoglobulin G (Immunoglobulin G)[1] Globulin, immune 💬 --[4] 14, 50, 63, 65 💬
11Human normal immunoglobulin G (IgG > 98% purity)----[3] 14, 63, 65 💬
12Human normal immunoglobulin G (IgG)----[1] 11 💬
13Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody----[1] 46 💬
14IMMUNOGLOBULIN G----[9] 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
15Immunoglobulin G (Ig NextGen 16%)----[1] 65 💬
16Immunoglobulin G cleaving cystein protease derived from E. coli----[2] 43, 44 💬
17Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy----[1] 2 💬
18Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer----[1] 2 💬
19Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer----[1] 49 💬
20Normal human immunoglobulin G[1] Human immunoglobulin G (Immunoglobulin G)[1] Globulin, immune 💬 --[1] 65 💬